Currently, there are over 240 closures, fabricated using a variety of elastomeric materials. claims Roots Analysis ! Knowpia

The materials used to fabricate pharmaceutical packaging components are extremely important to preserving the stability, efficacy and safety of drug formulations. In fact, according to the USFDA, in the last two years, there have been over 2,000 drug and device recalls owing to packaging-related concerns. Elastomeric closures, with various types of coatings (such as FluoroTec® and Teflon®), have emerged as a promising option for developing closures for pharmaceutical containers.

To order this 400+ page report, which features 185+ figures and 235+ tables, please visit this - https://www.rootsanalysis.com/reports/view_document/elastomeric-closures-market-focus-on-parenteral-containers-2019-2030/255.html

The USD 9.3 billion (by 2030) financial opportunity within elastomeric closures market has been analyzed across the following segments:

§ Type of packaging container

§ Vials

§ Syringes

§ Cartridges

§ Type of packaging closure

§ Seal

§ Stopper

§ Cap

§ Plunger

§ Barrel

§ Needle Shield

§ Sterilization status

§ Pre-sterilized

§ Unsterilized

§ Key geographical regions

§ North America

§ Europe

§ Asia Pacific

§ Rest of the World

The Elastomeric Closure Components Market For Vials, Cartridges and Syringes, 2019-2030 report features the following companies, which we identified to be key players in this domain:

§ Aptar Pharma

§ Daikyo Seiko

§ Datwyler Group

§ DWK Life Sciences

§ Hebei First Rubber Medical Technology (a Part of DESHENG Group)

§ Jiangsu Hualan New Pharmaceutical Material

§ Lonstroff (a Part of Sumitomo Rubber Industries)

§ Ompi (a Part of Stevanato Group)

§ West Pharmaceutical Services

Table of Contents

1. Preface

2. Executive Summary

3. Introduction